more snippets from QVH REPORT6 Jan 2023 10:52
PAGE 14 The Board had approved the full business case for the QVH community diagnostics centre
(CDC) at its private meeting on 1 September. IF, clinical SIRO for Sussex CDCs provided
some feedback from a recent meeting and reported that QVH continues to lead the
diagnostic breathlessness pathway nationally and had been applauded for work completed
to date and innovation with its technical partner. QVH has been nominated for a national
award for being a major disruptor.
PAGE 24
Community Diagnostic Centre (CDC)
We finally received confirmation on 23 December 2022 from the national team that our community
diagnostic centre (CDC) business case has been approved. This means we will receive £1.937m in
2023/24 and a further £6.706m the following financial year. QVH is already a CDC, providing
diagnostics for patients referred from local GP practices. The national funds will be invested in more
buildings, equipment and staff to significantly expand our CDC. The further development of the CDC
at QVH will mean more patients being able to have diagnostic tests nearer to home without the
need to go to an acute hospital with an A&E, where emergency care can lead to delays and
cancellations.
Electronic Patient Record (EPR)
EPR is a single electronic patient record which will replace the majority of our paper medical records.
This will mean that our clinical teams will have instant access to the data they need to care for
patients. The principle aim of a successful EPR deployment is to improve clinical outcomes and
safety for patients. EPR technology provides clinicians with modern clinical decision support tools at
their finger-tips reflecting best practice guidelines and recognised clinical standards.
QVH is currently in the process of bidding for Frontline Digitisation funding. This would cover the
majority of the programme costs for the first 5 years, the revenue impact of the support and
maintenance costs would not take effect until Year 6 – 2028/29.
The funding allocations have not yet been approved and are dependent on the development and
approval of a full business case, as well as any nationally mandated approval process associated with
the funding. At a private board meeting last month the Board considered an outline business case,
and agreed work should proceed to initiate the procurement for EPR and the development of a full
business case.